SAB Biotherapeutics, Inc. (SABS) Earnings
|
Expand Research on SABS
| Next EPS Date | N/A | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +19.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -4.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/7/25  |
Q225 | N/A | -$0.11 | N/A | N/A | $340K | N/A | N/A | N/A | ||
| 8/9/24 | Q224 | -$0.79 | $0.00 | -$0.79 | N/A | N/A | N/A |  | | Details | |
| 5/9/24 | Q124 | N/A | -$1.15 | N/A | N/A | $58.11K | N/A | N/A | N/A | ||
| 3/28/24 | Q423 | N/A | -$0.83 | N/A | N/A | $7.2K | N/A | N/A | N/A | ||
| 11/20/23 | Q323 | N/A | -$0.11 | N/A | N/A | $11.97K | N/A | N/A | N/A | ||
| 8/21/23 | Q223 | N/A | -$0.14 | N/A | N/A | $400K | N/A | N/A | N/A | ||
| 8/14/23 | Q223 | N/A | -$0.14 | N/A | N/A | $400K | N/A | N/A | N/A | ||
| 8/9/23 | Q223 | N/A | -$0.14 | N/A | N/A | $400K | N/A | N/A | N/A |
